You are here

TECHULON, INC.

Company Information
Address
602 N COLUMBUS ST
ALEXANDRIA, VA 22314-1849
United States


http://www.techulon.com

Information

UEI: WQFJVJ6BAMM8

# of Employees: 4


Ownership Information

HUBZone Owned: Yes

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Improving Wound Healing by Combating Multi-Drug Resistant Pathogens Using Small Molecule Antimicrobials

    Amount: $149,996.00

    Techulon has developed a platform based on peptide-peptide nucleic acids (PPNAs) molecules that are effective as antimicrobial compounds against multi-drug reisistant pathogens. Techulons targeted app ...

    SBIRPhase I2015Department of Defense Defense Health Agency
  2. Biologically-Derived Targeted Antimicrobials for Textile Applications

    Amount: $149,950.00

    Skin infections caused by bacteria represent a significant risk to wounded soldiers. The most common source of bacterial infection is found in the fabrics of clothing, boots, and gear worn by the war ...

    STTRPhase I2014Department of Defense Army
  3. Rapidly Adaptable Nanotherapeutics

    Amount: $1,858,492.00

    Infections caused by drug resistant bacteria create a $30b problem for the healthcare industry. Techulon has developed a Rapidly Adaptable NanoTherapeutic (RANT) approach to address this problem, whic ...

    SBIRPhase II2013Department of Defense Defense Advanced Research Projects Agency
  4. Rapidly Adaptable Nanotherapeutics

    Amount: $148,720.00

    Drug resistant pathogens represent a growing and significant risk. Post-treatment hospital infections account for over 90,000 deaths per year and an additional $30b in cost to the healthcare infrastru ...

    SBIRPhase I2012Department of Defense Defense Advanced Research Projects Agency
US Flag An Official Website of the United States Government